Babu Boga

Vice President of Medicinal Chemistry, Integrated Drug Discovery @Bioduro

San Diego, CA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2025 — Present

Vice President of Medicinal Chemistry, Integrated Drug Discovery @Bioduro

View department →

Facilitate Faster and Efficient Integrated Drug Discovery.Building a Strategic Collaboration Based on Trust, Quality, and Deliverables for long-term Success.

EDUCATION

1995 — 2000

Indian Institute of Technology, Madras

Doctor of Philosophy

2003 — 2005

Scripps Research

Post Doctoral, Total Synthesis of Natural Products under Prof. Dale Boger

2001 — 2003

Université catholique de Louvain, Belgium & Institut Européen de Chimie et Biologie, France

Post Doctoral, Heterocycle Chemistry and Medicinal Chemistry under Prof. Léon Ghosez

ABOUT BABU BOGA

Dr. Babu Boga, Ph.D, is Vice President of Medicinal Chemistry at BioDuro (a global CRDMO) brings deep expertise in Medicinal Chemistry driving Integrated Drug Discovery, Capabilities and Strategic growth. Dr. Boga has over two decades of experience in Drug Discovery, spanning in both pharmaceutical companies—including Merck and Schering-Plough (20••••18)—and innovative biotech firms such as Zentalis (20••••25).Dr. Boga earned his Ph.D.(2001; Best-PhD Thesis Award)) in Organic Chemistry and Carbohydrate Chemistry from the Indian Institute of Technology, Madras under the mentorship of Prof. K.K. Balasubramanian. He completed postdoctoral research (20••••03) in Heterocycles and Medicinal Chemistry at Université Catholique de Louvain, Belgium and IECB, France under Prof. Léon Ghosez, followed by a fellowship (20••••05) in Total Synthesis of Natural Products at The Scripps Research Institute, La Jolla, US under Prof. Dale Boger.Throughout his career, Dr. Boga has driven drug discovery across multiple therapeutic areas and modalities (Small molecules, Peptides, PROTACs and Carbohydrates, etc.). He is a co-inventor of several clinical candidates, including MK-8353/SCH-900353—Discovery of an orally bioavailable and dual mechanism ERK1/2 inhibitor targeting the MAPK/ERK signaling pathway in oncology. With over 64 publications and patents to his name, Dr. Boga exemplifies scientific innovation, strategic leadership, and a commitment to advancing human health.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Babu Boga — Vice President of Medicinal Chemistry, Integrated Drug Discovery at Bioduro in San Diego, CA, US | Unifers